{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:31:33Z","timestamp":1770435093610,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T00:00:00Z","timestamp":1323907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1038\/pr.2011.13","type":"journal-article","created":{"date-parts":[[2012,2,22]],"date-time":"2012-02-22T06:40:52Z","timestamp":1329892852000},"page":"39-45","source":"Crossref","is-referenced-by-count":28,"title":["Intrathecal recombinant human 4-sulfatase reduces accumulation of glycosaminoglycans in dura of mucopolysaccharidosis VI cats"],"prefix":"10.1038","volume":"71","author":[{"given":"Dyane","family":"Auclair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Finnie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven U.","family":"Walkley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joleen","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alphonsus","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Hopwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,15]]},"reference":[{"key":"BFpr201113_CR1","first-page":"1565","volume-title":"The Metabolic Basis of Inherited Disease","author":"EF Neufeld","year":"1989","unstructured":"Neufeld EF, Muenzer J . The mucopolysaccharidoses. In: Scriver C, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. New York: McGraw-Hill, 1989: 1565\u20131587."},{"key":"BFpr201113_CR2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1148\/125.2.421","volume":"125","author":"RD Sostrin","year":"1977","unstructured":"Sostrin RD, Hasso AN, Peterson DI, Thompson JR . Myelographic features of mucopolysaccharidoses: a new sign. Radiology 1977;125: 421\u20134.","journal-title":"Radiology"},{"key":"BFpr201113_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1227\/00006123-198401000-00020","volume":"14","author":"SL Wald","year":"1984","unstructured":"Wald SL, Schmidek HH . Compressive myelopathy associated with type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome). Neurosurgery 1984;14: 83\u20138.","journal-title":"Neurosurgery"},{"key":"BFpr201113_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000050383","volume":"35","author":"VI Vougioukas","year":"2001","unstructured":"Vougioukas VI, Berlis A, Kopp MV, Korinthenberg R, Spreer J, van Velthoven V . Neurosurgical interventions in children with Maroteaux-Lamy syndrome. Case report and review of the literature. Pediatr Neurosurg 2001;35: 35\u20138.","journal-title":"Pediatr Neurosurg"},{"key":"BFpr201113_CR5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.clineuro.2004.05.003","volume":"107","author":"M Mut","year":"2005","unstructured":"Mut M, Cila A, Varli K, Akalan N . Multilevel myelopathy in Maroteaux-Lamy syndrome and review of the literature. Clin Neurol Neurosurg 2005;107: 230\u20135.","journal-title":"Clin Neurol Neurosurg"},{"key":"BFpr201113_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0730-725X(87)90120-2","volume":"5","author":"MV Kulkarni","year":"1987","unstructured":"Kulkarni MV, Williams JC, Yeakley JW, et al. Magnetic resonance imaging in the diagnosis of the cranio-cervical manifestations of the mucopolysaccharidoses. Magn Reson Imaging 1987;5: 317\u201323.","journal-title":"Magn Reson Imaging"},{"key":"BFpr201113_CR7","first-page":"223","volume":"47","author":"E Kachur","year":"2000","unstructured":"Kachur E, Del Maestro R . Mucopolysaccharidoses and spinal cord compression: case report and review of the literature with implications of bone marrow transplantation. Neurosurgery 2000;47: 223\u20138; discussion 228\u20139.","journal-title":"Neurosurgery"},{"key":"BFpr201113_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","volume":"148","author":"P Harmatz","year":"2006","unstructured":"Harmatz P, Giugliani R, Schwartz I, et al.; MPS VI Phase 3 Study Group. Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study. J Pediatr 2006;148: 533\u20139.","journal-title":"J Pediatr"},{"key":"BFpr201113_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ymgme.2008.04.001","volume":"94","author":"P Harmatz","year":"2008","unstructured":"Harmatz P, Giugliani R, Schwartz IV, et al.; MPS VI Study Group. Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase. Mol Genet Metab 2008;94: 469\u201375.","journal-title":"Mol Genet Metab"},{"key":"BFpr201113_CR10","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1172\/JCI119208","volume":"99","author":"AC Crawley","year":"1997","unstructured":"Crawley AC, Niedzielski KH, Isaac EL, Davey RC, Byers S, Hopwood JJ . Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI. J Clin Invest 1997;99: 651\u201362.","journal-title":"J Clin Invest"},{"key":"BFpr201113_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1096-7192(03)00007-6","volume":"78","author":"D Auclair","year":"2003","unstructured":"Auclair D, Hopwood JJ, Brooks DA, Lemontt JF, Crawley AC . Replacement therapy in mucopolysaccharidosis type VI: advantages of early onset of therapy. Mol Genet Metab 2003;78: 163\u201374.","journal-title":"Mol Genet Metab"},{"key":"BFpr201113_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ymgme.2007.04.009","volume":"91","author":"D Auclair","year":"2007","unstructured":"Auclair D, Hopwood JJ, Lemontt JF, Chen L, Byers S . Long-term intra-articular administration of recombinant human N-acetylgalactosamine-4-sulfatase in feline mucopolysaccharidosis VI. Mol Genet Metab 2007;91: 352\u201361.","journal-title":"Mol Genet Metab"},{"issue":"4 Pt 1","key":"BFpr201113_CR13","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1203\/01.pdr.0000203090.41012.a6","volume":"59","author":"D Auclair","year":"2006","unstructured":"Auclair D, Hein LK, Hopwood JJ, Byers S . Intra-articular enzyme administration for joint disease in feline mucopolysaccharidosis VI: enzyme dose and interval. Pediatr Res 2006;59(4 Pt 1): 538\u201343.","journal-title":"Pediatr Res"},{"key":"BFpr201113_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ymgme.2009.10.002","volume":"99","author":"D Auclair","year":"2010","unstructured":"Auclair D, Finnie J, White J, et al. Repeated intrathecal injections of recombinant human 4-sulphatase remove dural storage in mature mucopolysaccharidosis VI cats primed with a short-course tolerisation regimen. Mol Genet Metab 2010;99: 132\u201341.","journal-title":"Mol Genet Metab"},{"key":"BFpr201113_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ymgme.2004.07.003","volume":"83","author":"E Kakkis","year":"2004","unstructured":"Kakkis E, McEntee M, Vogler C, et al. Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I. Mol Genet Metab 2004;83: 163\u201374.","journal-title":"Mol Genet Metab"},{"key":"BFpr201113_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ymgme.2006.12.012","volume":"91","author":"P Dickson","year":"2007","unstructured":"Dickson P, McEntee M, Vogler C, et al. Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid. Mol Genet Metab 2007;91: 61\u20138.","journal-title":"Mol Genet Metab"},{"key":"BFpr201113_CR17","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1203\/01.PDR.0000113789.30640.5C","volume":"55","author":"A Crawley","year":"2004","unstructured":"Crawley A, Ramsay SL, Byers S, Hopwood J, Meikle PJ . Monitoring dose response of enzyme replacement therapy in feline mucopolysaccharidosis type VI by tandem mass spectrometry. Pediatr Res 2004;55: 585\u201391.","journal-title":"Pediatr Res"},{"key":"BFpr201113_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1172\/JCI935","volume":"101","author":"AC Crawley","year":"1998","unstructured":"Crawley AC, Yogalingam G, Muller VJ, Hopwood JJ . Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes. J Clin Invest 1998;101: 109\u201319.","journal-title":"J Clin Invest"},{"key":"BFpr201113_CR19","first-page":"769","volume":"49","author":"PJ Meikle","year":"2003","unstructured":"Meikle PJ, Fuller M, Hopwood JJ . Mass spectrometry in the study of lysosomal storage disorders. Cell Mol Biol (Noisy-le-grand) 2003;49: 769\u201377.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"BFpr201113_CR20","doi-asserted-by":"publisher","first-page":"725","DOI":"10.7863\/jum.1997.16.11.725","volume":"16","author":"H Kuchiwaki","year":"1997","unstructured":"Kuchiwaki H, Inao S, Ishii N, Ogura Y, Gu SP . Human dural thickness measured by ultrasonographic method: reflection of intracranial pressure. J Ultrasound Med 1997;16: 725\u201330.","journal-title":"J Ultrasound Med"},{"key":"BFpr201113_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s11547-008-0352-8","volume":"114","author":"R Grassi","year":"2009","unstructured":"Grassi R, Cavaliere C, Cozzolino S, et al. Small animal imaging facility: new perspectives for the radiologist. Radiol Med 2009;114: 152\u201367.","journal-title":"Radiol Med"},{"key":"BFpr201113_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1089\/neu.2007.0348","volume":"25","author":"JT Maikos","year":"2008","unstructured":"Maikos JT, Elias RA, Shreiber DI . Mechanical properties of dura mater from the rat brain and spinal cord. J Neurotrauma 2008;25: 38\u201351.","journal-title":"J Neurotrauma"},{"key":"BFpr201113_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ymgme.2009.07.013","volume":"98","author":"KM Hemsley","year":"2009","unstructured":"Hemsley KM, Norman EJ, Crawley AC, et al. Effect of cisternal sulfamidase delivery in MPS IIIA Huntaway dogs. Mol Gen Met 2009;98: 383\u201392.","journal-title":"Mol Gen Met"},{"key":"BFpr201113_CR24","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/j.1460-9568.2009.06666.x","volume":"29","author":"KM Hemsley","year":"2009","unstructured":"Hemsley KM, Luck AJ, Crawley AC, et al. Examination of intravenous and intra-CSF protein delivery for treatment of neurological disease. Eur J Neurosci 2009;29: 1197\u2013214.","journal-title":"Eur J Neurosci"},{"key":"BFpr201113_CR25","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/j.1601-183X.2008.00413.x","volume":"7","author":"KM Hemsley","year":"2008","unstructured":"Hemsley KM, Beard H, King BM, Hopwood JJ . Effect of high dose, repeated intra-cerebrospinal fluid injection of sulphamidase on neuropathology in MPS IIIA mice. Genes Brain Behav 2008; 7: 740\u201353.","journal-title":"Genes Brain Behav"},{"key":"BFpr201113_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ymgme.2006.10.005","volume":"90","author":"KM Hemsley","year":"2007","unstructured":"Hemsley KM, King B, Hopwood JJ . Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice. Mol Genet Metab 2007;90: 313\u201328.","journal-title":"Mol Genet Metab"},{"key":"BFpr201113_CR27","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1002\/ajmg.a.32294","volume":"146A","author":"MV Munoz-Rojas","year":"2008","unstructured":"Munoz-Rojas MV, Vieira T, Costa R, et al. Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression. Am J Med Genet A 2008;146A: 2538\u201344.","journal-title":"Am J Med Genet A"},{"key":"BFpr201113_CR28","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ymgme.2009.11.008","volume":"99","author":"MV Mu\u00f1oz-Rojas","year":"2010","unstructured":"Mu\u00f1oz-Rojas MV, Horovitz DD, Jardim LB, et al. Intrathecal administration of recombinant human N-acetylgalactosamine 4-sulfatase to a MPS VI patient with pachymeningitis cervicalis. Mol Genet Metab 2010;99: 346\u201350.","journal-title":"Mol Genet Metab"},{"key":"BFpr201113_CR29","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/j.1365-2990.2005.00675.x","volume":"31","author":"SU Walkley","year":"2005","unstructured":"Walkley SU, Thrall MA, Haskins ME, et al. Abnormal neuronal metabolism and storage in mucopolysaccharidosis type VI (Maroteaux-Lamy) disease. Neuropathol Appl Neurobiol 2005;31: 536\u201344.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"BFpr201113_CR30","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1208\/s12248-008-9043-6","volume":"10","author":"JT White","year":"2008","unstructured":"White JT, Martell LA, Van Tuyl A, et al. Development, validation, and clinical implementation of an assay to measure total antibody response to naglazyme (galsulfase). AAPS J 2008;10: 363\u201372.","journal-title":"AAPS J"},{"key":"BFpr201113_CR31","first-page":"65","volume":"6","author":"S  Holm","year":"1979","unstructured":"Holm S . A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6: 65\u201370","journal-title":"Scand J Stat"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr201113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr201113","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr201113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:54:47Z","timestamp":1684472087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr201113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,15]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["BFpr201113"],"URL":"https:\/\/doi.org\/10.1038\/pr.2011.13","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,15]]}}}